Trial intelligence / Profile preview

Quetiapine versus alprazolam for insomnia after coronary artery bypass graft surgery

IRCT20160716028945N4Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Jun 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, double-blind trial of alprazolam in Insomnia (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Insomnia Score according to ISI questionnaire. Started Jun 2017; status: completed.

02

Drugs

alprazolam
03

Conditions

Insomnia

Beyond the preview

Go deeper on IRCT20160716028945N4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20160716028945N4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call